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Abstract:

Vitamin D has been linked to breast cancer risk in animal and human studies, suggesting that the
active metabolite 1,25-Dihydroxyvitamin D (1,25D) might protect breast cells from
transformation. In human mammary epithelial (HME-hTERT) cells, which express vitamin D
receptor (VDR), 1,25D exerts anti proliferative and pro-differentiating effects, but the molecular
mechanisms that mediate these actions are unknown. In previous studies we used genomic
profiling to classify 1,25D regulated networks in HME-hTERT cells that may contribute to the
anti-cancer effects of vitamin D. Through this approach we detected a 60-fold increase in the
cytokine CD14 in HME-hTERT cells treated with vitamin D. CD14 is a component of the innate
immune system which also functions in apoptotic cell clearance and mammary gland
remodeling. The studies described in the first part of this thesis were designed to confirm and
extend this preliminary data. HME-hTERT cells, which were used to generate the preliminary
data, and HME-PR cells, a transformed derivative, and HC11 cells, mouse mammary epithelial
cells, were cultured and treated with vitamin D metabolites (25-hydroxyvitamin D and 1,25dihydroxyvitamin D). Doses ranged from 0-100nM, and duration of treatment was 24h. qPCR
was used to analyze the expression of CD14 and related immune response genes. These studies
determined the extent to which 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D alter the
synthesis or secretion of cytokines in mammary cells (both human and mouse) and how
transformation alters the basal and vitamin D-induced expression of these cytokines. Our data
suggest that vitamin D regulation of cytokines is altered during the process of carcinogenesis and
that the specific targets of VDR that regulate immune responses differ in human and mouse cells.

In addition to effects on immune responses, the anti-cancer effects of vitamin D have been linked
to modulation of the extraceullular matrix. In previous studies, the Welsh lab identified Has2
(hyaluronic acid synthase 2) as a vitamin D regulated gene in invasive murine mammary cancer
cells. Has2 is the rate-limiting enzyme in the synthesis of hyaluronic acid (HA), which
accumulates in the extracellular matrix. Has2 over-expression and HA synthesis have been
linked to cancer cell invasion and metastasis in vitro and abnormal skin phenotypes in vivo. The
abnormal skin phenotype associated with Has2 over-expression is highly similar to skin changes
reported in VDR knockout (VDRKO) mice, suggesting that Has2 regulation by VDR may have
functional consequences in vivo. In the second part of this thesis project, we further investigated
the link between VDR and Has2 expression/function in skin and mammary tissue of mice.
Tissues from wildtype and VDRKO mice of different ages were sectioned and processed for
Has2 (immunofluorescence), HA (HABP binding assay) and proteoglycans (alcian blue
staining). Additional in vitro studies were conducted to establish western blotting and PCR
assays for study of this pathway. Our data suggest that vitamin D and the VDR physiologically
regulate Has2 and HA production in vivo, especially in the epidermis.
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I. INTRODUCTION

Vitamin D is essential for growth and development in most biological systems. There are two
naturally occurring forms of vitamin D—vitamin D2 and vitamin D3. Vitamin D2 is synthesized
in plants while D3 is synthesized in animals. The vitamin D present in humans can be generated
by UVB radiation or can be obtained from the diet and supplements. UVB radiation converts 7dehydrocholesterol in the skin to pre-vitamin D3 which, through a heat dependent process,
isomerizes into vitamin D3. Once generated, a vitamin D binding protein (DBP), which is
present in serum, binds vitamin D3 and transports it to the liver. In the liver, vitamin D3 is
converted to 25-hydroxyvitamin D by the enzyme 25-hydroxylase. 25-hydroxyvitamin D3 is
then circulated to the kidneys to be converted into the active form 1,25-dihydroxyvitamin D
(1,25 D) by the 1-alpha hydroxylase enzyme. The biological actions of vitamin D are mediated
by 1,25D which is the ligand for the vitamin D receptor (VDR). The VDR belongs to the nuclear
receptor family which are trans-acting transcriptional regulatory factors.

The VDR

heterodimerizes with the retinoid X-receptor (RXR) and this complex binds to vitamin D
response elements on DNA which modulates the expression of target genes (Kato 2000). Once
the VDR is liganded and bound to RXR the complex activates or represses specific target genes
in each tissue.

Vitamin D’s best characterized function is the regulation of calcium and phosphorus absorption
which is essential for maintenance of muscle and bone health. Yet vitamin D also functions as
an immunomodulator which contributes to the prevention of autoimmune diseases and the
control of invading pathogens. In addition, vitamin D regulates cell growth and differentiation
in many epithelial tissues including the mammary gland and skin Many epidemiological
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studies have demonstrated that high vitamin D status correlates with reduced risk for chronic
diseases including cancer.

The immune regulatory effects of vitamin D have been demonstrated in animal models of
autoimmune disease (Deluca and Cantorna 2001). In these studies, both vitamin D deficiency
and the absence of the VDR enhanced disease development and severity. Other reports have
demonstrated anti-inflammatory effects of vitamin D through effects on macrophages and other
immune cells. However, very few studies have examine whether vitamin D alters immune genes
in epithelial cells. Interestingly, microarray analysis in the lab of my mentor Dr JoEllen Welsh,
indicated that immune regulatory genes were up regulated in human mammary epithelial (HMEhTERT) cells treated with 100nM of 1,25 D for 24 hours. Some of the immune regulatory genes
that were identified in the Welsh studies include CD14, cathelicidin (CAMP), defensin β1
(DEFB1), and select interleukins (IL).

In the first part of my thesis work, I conducted

experiments to validate and extend these data on regulation of immune genes in mammary cells
treated with vitamin D.

The anti-cancer effects of vitamin D have also been well studied at the cell and molecular level.
In vitro and in vivo studies have consistently demonstrated that vitamin D exerts antiproliferative and pro-apoptotic effects on cancer cells (Daniellson et al 1984). Cancer cell
models have been developed in the Welsh lab to study the mechanisms by which vitamin D
inhibits proliferation. One model employs transformed mouse mammary cells derived from wildtype (WT) and VDR knockout (VDRKO) mice. In this model system, microarray analysis found
that the expression of the hyaluronan synthase 2 (Has2) gene was down regulated by 1,25 D
(100nM, 24h). Has2 is an enzyme that synthesizes hyaluronic acid (HA), an extracellular glycan
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which activates cell proliferation and has been linked to cancer progression in many studies
(Matthews et al 2010). In the second part of my project I focused on the regulation of Has2 by
vitamin D in cell and animal models of cancer.

The overall goal of my project was to further elucidate the role of vitamin D in normal and
cancerous cells and tissues. In the first series of studies, I measured the effect of vitamin D
metabolites on the expression of select immunological genes in normal human (HME-hTERT
cells) and mouse (HC-11 cells) cell lines and in a cancerous variant of the HME-hTERT cells
(HME-PR cells). The studies were designed to test the hypothesis that the induction of the
immunological genes CAMP, CD14, DEFB1, IL1A, and IL1B by vitamin D would be similar
in the normal cell lines derived from human and mouse, but would be reduced in the cancerous
HME-PR cells.

In the second series of studies, I investigated the link between the VDR and

Has2 in vivo using mammary and skin tissues and cells from WT and VDRKO mice. These
studies were designed to test the hypothesis that the expression of Has 2 would be deregulated
in the tissue of VDRKO mice compared to WT mice.
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II. EFFECTS OF VITAMIN D ON CYTOKINE SYNTHESIS IN NORMAL AND
TRANSFORMED MAMMARY EPITHELIAL CELLS.

a. Rationale for Study

Genomic profiling of mammary epithelial cells demonstrated a cohort of immune regulatory
genes that were altered by 1,25D. Several of these genes [CD14, CAMP, DEFB1 and ILs (IL1A,
IL1B, IL10, IL-6)] are important mediators of the innate immune response and were chosen for
follow-up studies. CD14 plays a major role in innate immunity through interaction with the toll
like receptor 4 (TLR4). CD14 is a pattern recognition receptor that binds lipopolysaccharide
(LPS). There are two forms of CD14; soluble CD14 and membrane CD14. Both forms of CD14
bind LPS and transport it to TLR4 which activates the TLR4 signaling pathway activating a proinflammatory cellular response. TLR4 is a protein that detects liposaccharides in the gramnegative bacteria; thus it helps activate the innate immune system.

CAMP is an antimicrobial polypeptide that can be found in lysosomes, macrophages, and
leukocytes. The CAMP polypeptide is activated by bacteria, viruses, fungi, or 1,25-D. CAMP
primarily functions as an innate immune defense against bacterial infection.

DEFB1 is an

antimicrobial protein that is a part of the defensin family of cytotoxic peptides. DEFB1 and
other defensins are cationic proteins. Defensins function by impeding gene expression and
preventing viruses from entering their target cells.

Interleukins (IL) are produced primarily by macrophages in the body as proproteins. Proproteins
are proteins that are cleaved to form an active protein; the ability to do this can be turned on and
off. IL1A and IL1B play an important role in the pro-inflammatory immune response by
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mediating cell differentiation, proliferation, and apoptosis. These cytokines are able to slow the
rate of proliferation of cells and to repress the half-life of mRNA. IL6 plays a role in both the
pro-inflammatory and anti-inflammatory response; it is found in T cells, B cells, monocytes, and
PMNs.

It is known to induce the acute-phase protein response when acting in the pro-

inflammatory immune system. When acting as an anti-inflammatory gene it is known to inhibit
TNF and IL1 production by macrophages (Opal et al, 2004).

IL10 is a major player with

regards to the anti-inflammatory immune response. It comes from monocytes and macrophages,
and T and B cells. IL10 inhibits monocyte/macrophage and neutrophil cytokine productions as
wells as inhibiting lymphocyte response (Opal et al, 2004).

b. Materials and Methods

The HME-hTERT cells and the HME-PR cells were split and cultured in 171 Media (Gibco)
containing growth supplement (EGF, insulin, hydro-cortisone and pituitary extract). The HMEPR cells were plated in well plates and treated with 1,25 D or 25D and vehicle (ethanol) for 24
hours. After treatment, RNA was harvested from the HME-PR cells following an established
protocol using the kit reagents: Buffer RLT, Buffer RW1, and Buffer RPE.

The HC11 cells were split and cultured in RPMI Media which contains 250uL 20ng/uL Mouse
EGF, 500uL of 50 mg/mL Gentamicin, 5mL 200mM Glutamine (Glutamax), and 50mL of Fetal
Bovine Serum (FBS) per 500mL of media. 50uL of insulin was added for every 10mL of media.
The HC11 cells were plated in well plates and treated with a concentration ranging from 0100nM 1,25D or 25D and vehicle (ethanol) for 24 hours. After treatment, RNA was harvested
using the same established protocol used when harvesting HME-PR cell RNA.
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After RNA was isolated, it was purified using the Qiagen RNeasy protocol. The protocol uses a
silica-based membrane and high-salt buffers to isolate RNA longer than 200 bases.

This

protocol specifically selects for the messenger RNA (mRNA). The mRNA concentration and
integrity was then measured using the nanodrop (NANODROP ND-1000 Spectrophotometer).

The isolated RNA was then used to prepare cDNA (complimentary DNA) through reverse
transcription (RT) for polymerase chain reaction (PCR) analysis. Reverse transcription occurs
when the purified RNA strand’s complimentary base pairs are formed thus creating a DNA
strand. There are three steps when preparing cDNA in the Mastercycler gradient machine
(Eppendorf): the first brings the DNA to 25˚C for 10 minutes, the temperature then rises to 37˚C
for one hour, and finally the temperature rises to 95˚C for five minutes. Once all steps are done,
the samples are held at 4˚C. RT master mix includes RT Buffer, MgCl, dNTPs, Random
Hexamers, RNAse Inhibitor, and Muiltiscribe RT.

The cDNA was then used for quantitative (q) PCR. qPCR is a method used for
quantitating changes in gene expression of genes of interest. The genes of interest in this
experiment were CD14, CAMP, DEFB1, IL1A, IL1B, IL6, IL10, and TLR4. 18S was also
measured as a normalization control. The experimental primers targeting the genes of interest
and SYBR green were used in this experiment. SYBR Green binds to DNA and fluoresces as the
PCR product accumulates allowing for product to be detected and recorded. The 1,25 D and
vehicle treated HME-PR cell cDNA samples were plated in duplicate in a 384 well plate. Once
plating was done, RT PCR was performed using the 7900HT Fast Real-Time PCR system
(Applied BioSystems). The thermocycler begins by bringing the plate with samples to 50˚C for
two minutes.

Then the temperature rises to 95˚C for 10 minutes.
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In the final step, the

temperature is kept at 95˚ for 15 seconds and then lowered to 60˚C for one minutes. These steps
are repeated 40 times until finished. For each primer, gene expression was normalized to 18S
expression. The data is presented as fold change in gene expression in treated samples (1,25D or
25D) relative to vehicle treated control samples.

c. Results

In this series of studies on vitamin D regulation of immune genes, we evaluated the effects of
vitamin D on several genes that mediate innate immune responses. We first conducted
comparative studies in normal and cancerous mammary cells. qPCR assays were used to assess
gene expression in cells treated with 100nM 1,25D for 24 hours. Fold change for each gene was
calculated and graphed.

Figure 1A displays the average fold change of the various genes tested—CAMP, CD14, DEFB1,
IL1A, and IL1B—in non-cancerous HME-hTERT cells.

Fold change was calculated by

normalizing experimental data against the ethanol control. In the HME-HTERT cells, CAMP
was induced 3-fold by 1,25D.

CD14 was induced 232.2-fold by 1,25D.

There were no

significant differences in the expression of DEFB1, IL1A, and IL1B between vehicle and 1,25D
treated cells.

Figure 1B displays the average fold change of the various genes tested—CAMP, CD14, DEFB1,
IL1A, and IL1B—in HME-PR cells. In HME-PR cells, CAMP has the largest observed fold
change at 13.33. CD14 has the next largest observed fold change at 9.97. No significant
differences in DEFB1 or IL1A were detected between vehicle and 1,25D treated cells. IL1B was
induced 6-fold in 1,25D treated cells compared to vehicle treated cells.
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Figure 1C shows the average fold change for the same genes, except IL1A, in HME-PR cells
treated with 100nM 25D. In response to 25D treatment CD14 was induced at 3-fold. CAMP
and IL1B were induced 2-fold when treated with 25D. No significant difference was detected in
DEFB1.

1A

1B

250
200
150

Fold Change

100
50
10
9
8
7
6
5
4
3
2
1
0
CD14

CAMP

DEFB1

IL1A

IL1B

Genes

1C

DEFB1

Genes

Figure 1. Immune gene expression in
mammary cells treated with 1,25D or 25D. A,
Expression of CD14, CAMP, DEFB1, IL1A,
and IL1B in HME cells treated with 100nM
1,25D for 24 hours. B, Expression of CD14,
CAMP, DEFB1, IL1A, and IL1B in HME-PR
cells treated with 100nM 1,25D for 24 hours.
1C,Expression of CD14, CAMP, DEFB1, IL1A,
and IL1B in HME-PR cells treated with 100nM
25D for 24 hours.Bars represent mean±standard
error of values normalized to vehicle control
ll

In order to determine whether mouse models would be useful in assessing vitamin D effects on
immune responses in mammary gland, we next tested the effects of vitamin D compounds on
immune gene expression in a mouse mammary epithelial cell line (HC11). As demonstrated in
Figure 2, we tested the effects of both 1,25D (2A,C) and 25D (2B,D) in these studies.

The

results (Fig 2A) indicate trends for 1,25D (at concentrations of 25nM and above) to enhance the
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expression of

CD14, TLR4, and IL6 in the HC11 cells but these differences were less than 2-

fold and were not statistically significant. Likewise, 25D at concentrations of 50nM and above
appeared to enhance expression of CD14, TLR4 and IL-6 but these differences were not
statistically significant.
vitamin D compounds,

In contrast to these three genes which were marginally affected by
1,25D dose dependently increased the expression of the anti-

inflammatory cytokine IL10 in HC11 cells, with a 5-fold increase at 5nM, 12-fold at 25nM, 14fold at 50nM and 17-fold at 100nM (Fig 2C). In cells treated with 25D, the induction of IL-10
was less than that seen with 1,25D (maximum induction of 2.6 fold was observed at 50nM).

2A

2B

2C

2D

Figure 2. Regulation of cytokine gene expression by 1,25D and 25D in HC11 cells. A,
Expression of CD14, TLR4, and IL6 in HC11 cells treated with 1,25D for 24 hours. B,
Expression of CD14, TLR4, and IL6 in HC11 cells treated with 100nM 25 for 24 hours. C,
Expression of IL10 in HC11 cells treated with 0-100nM 1,25D for 24 hours. D, Expression
of IL10 in HC11 cells treated with 0-100nM 25D for 24 hours. Bars represent
mean±standard error of values normalized to vehicle control cells.
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d. Discussion

In these experiments, PCR analysis was conducted on various mammary epithelial cell lines
(HME-hTERT cells, HME-PR cells and HC11 cells) to determine the effects of vitamin D on
immune gene expression. HME-hTERT cells (human mammary epithelial cells) were derived
from the mammary gland of a healthy female donor and represent a normal mammary cell line.
HME-PR cells were generated from the HME-hTERT cell line through introduction of
oncogenes leading to p53 disruption and Ras activation. These cells are invasive and tumorigenic
and thus represent a cancerous cell line. HC11 cells were derived from mammary gland of
BALB mice (Danielson et al, 1984) and represent the murine equivalent of the normal HMEhTERT cells. The immune genes studied in this PCR analysis were CD14, CAMP, DEFB1,
IL1A, and IL1B (HME-hTERT and HME-PR cells), and CD14, TLR4, IL6, and IL10 (HC11
cells).

As seen in Figure 1, which compares immune gene expression in HME-hTERT cells versus
HME-PR cells treated with vitamin D metabolites, the cancerous HME-PR cells are in general
less sensitive to vitamin D mediated immune gene regulation. The data were calculated as fold
change which refers to the difference in gene expression between ethanol (vehicle) treatment and
vitamin D treatment within each cell line. The induction of CD14 gene expression in the HMEPR cells, both 1,25 D and 25D treated (10 fold change and 3 fold change respectively) was much
less than that observed in HME-hTERT cells (200 fold change). DEFB1 gene expression was
not increased in HME-PR cells treated with either 1,25D or 25D but was 2-fold increased in the
HME-hTERT cells. IL1A was not altered in either cell line treated with 1,25D and therefore was
not tested in 25D treated cells.
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Exceptions to the general observation of reduced vitamin D mediated effects in HME-PR cells
were seen with CAMP and IL1B gene expression. In HME-PR cells treated with 1,25D, CAMP
was increased in 13 fold as compared to only 3 fold in HME-hTERT cells. Also, when HMEPR cells were treated with 25D, CAMP expression decreased 2 fold, as compared to change)
was seen. For IL1B, gene expression was increased in the HME-PR cells (6 fold change: 1,25D
treatment and 2 fold change: 25D treatment) but was unaffected in the HME –hTERT cells.

In the normal mouse mammary cell line HC11 treatment with varying doses of 1,25D for 24
hours only marginally increased CD14, TLR4 and IL-6, suggesting that these genes may not be
under vitamin D control in murine cells. For most genes, only slight induction (less than 2-fold)
was evident, begining at 25nM for 1,25D and 50nM for 25D. For both vitamin D metabolites
these effects plateaued at doses greater than 50nM. Interestingly, IL10 was dose-dependently upregulated by 1,25D (and to a lesser extent by 25D) in the HC11 cells with peak induction of 15fold by 100nM 1,25D. Since IL-10 mediates anti-inflammatory effects, this observation may be
relevant to the reported increased inflammation in the mammary gland of VDRKO mice (Welsh
et al, 2010).

The genes examined in HC11 cells (CD14, TLR4, IL6, and IL10) were selected because they are
known to be regulated by vitamin D in human cells. CD14 plays a major role in activating the
TLR4 signaling pathway by binding to LPS. Once CD14 binds to LPS, the first line of cell
defense—the TLR4 signaling pathway—is triggered, thus allowing for the innate immune
system to be activated. IL6 is a known pro-inflammatory cytokine. On the other hand, IL10 is a
known anti-inflammatory cytokine. If the TLR4 signaling pathway is activated by the binding of
CD14, an up-regulation of IL6 would be found. However, if the TLR4 signaling pathway is not
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activated, an anti-inflammatory response (in this case, by IL10) is induced. The limited upregulation of CD14, TLR4, and IL6 by vitamin D in the HC11 cells, with concomitant upregulation of IL-10, suggests that an anti-inflammatory response might be triggered in the
presence of 1,25D. Since published work has indicated interaction between vitamin D and IL-10
in mouse models of colon inflammation, further studies would be of interest to examine this
connection in mammary gland.

In summary, these are the first studies to compare the effects of vitamin D metabolites on
immune response genes in normal and cancerous mammary cells and to examine whether these
effects are conserved in human and mouse models.

Although our results indicate some

interesting trends that suggest altered immune gene regulation by 1,25D in cancer cells, and
distinct target genes for VDR in human vs mouse cells, additional studies are needed to confirm
these results. The experiments shown here need to be repeated due to high standard deviation.
Furthermore, since all our studies were conducted after 24h treatment, it would be of interest to
examine cells for longer periods of time This is especially important in the case of 25D because
it requires enzymatic conversion into 1,25D for activity and this may not be complete within the
24h time frame used.
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III. REGULATION OF HAS2 BY VDR IN MAMMARY GLAND AND EPIDERMIS
a. Rationale for Study

In a microarray screen of mouse breast cancer cells, the expression of the Hyaluronan synthase
2 (Has2) gene was down regulated by 1,25D (100nM, 24h). Has2 is an enzyme that, along with
Has1 and Has3, synthesizes hyaluronic acid (HA). HA is known to play a major structural and
functional role in extracellular matrices and body fluids by “binding to other matrix molecules
like proteoglycans, thereby organizing the architecture and regulating the mechanical properties
of tissues” (Rilla et al, 2010) such as cartilage. HA creates an optimal environment for cell
growth and renewal. In addition, it can act as a signaling molecule in which it activates events in
cells which “influence processes such as proliferation, migration, adhesion, apoptosis, cell shape,
and multi-drug resistance” (Rilla et al, 2010). That is, HA can be linked to the proliferation of
tumor cell lines and eventual cancer.

HA is known to be degraded by hyaluronidases (Hyal)

there are three isoforms —Hyal1, Hyal2, and Hyal 3. The amount of HA in individual tissues
therefore depends on the relative expression and activity of three Has genes and three Hyal
genes. Two tissues in which Has2 and/or HA have been consistently linked to proliferation and
carcinogenesis are the skin and the mammary gland. Of relevance to this project, both skin and
mammary gland of VDRKO mice display hyperproliferation and are highly susceptible to
chemically induced carcinogenesis. Therefore our observation that vitamin D regulates Has2 in
mouse breast cancer cells suggests that accumulation of HA may contribute to the abnormalities
in mammary gland and skin that develop in VDRKO mice (Welsh, 2007). In support of this
suggestion,

genetic analyses have shown that the wrinkly skin phenotype in Shar Pei dogs,

which resembles that of the VDRKO mice, results from duplication of the Has2 gene (Olsson et
al, 2011).
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b. Materials and Methods

In the first series of experiments we examined normal and cancerous tissues which were archived
from previous studies on WT and VDRKO mice. For normal tissue, we analyzed mammary
gland from mature adult female mice. For mammary tumors, mice were treated with the
chemical carcinogen DMBA to induce tumor growth. Normal skin tissue was collected from
adult male mice. All tissues were fixed in formalin and embedded in paraffin for sectioning.
After sectioning was complete, three different staining protocols were used for detection. For the
immunohistochemistry protocol to detect Has2, the tissues were first deparafinized and
rehydrated. Next, endogenous peroxidase activity was quenched by treating with 3% hydrogen
peroxide. Dako Protein Block was utilized to block for 10 minutes. Tissues were then incubated
with the primary antibody for 1 hour at room temperature. Once incubation was complete,
tissues were washed 3 times with PBS.

After, tissues were incubated with Biotinylated

Secondary from the VECTASTAIN kit for half an hour. Once again, tissues were washed 3
times with PBS. Tissues were then incubated for half an hour with ABC Reagent (from the
VECTASTAIN kit).

PBS was used to wash the tissues 3 times after completion.

DAB

chromogen was used on the tissues and allowed to develop to an appropriate stain. Tissues were
then counterstained with hematoxylin.

After counterstaining, tissues were dehydrated and

mounted.

For the HA binding protein staining protocol, tissues were first deparafinized and rehydrated.
Endogenous peroxidase activity was quenched by treatment with 3% hydrogen peroxide. When
this was finished, tissues were rinsed with PBS. Next serum free blocking solution (Dako
Protein block) was used. Slides were then incubated with Bovine HABP (bHABP) overnight at
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4°C. The next day, slides were rinsed with PBS. Detection with the tertiary reagent of the
VECTASTAIN Elite ABC kit was done. DAB substrate was then placed on tissue sections and
allowed to develop to an appropriate stain. Sections were then rinsed, and counterstained with
hematoxylin. After this was completed, sections were dehydrated and mounted.

The Alcian blue staining protocol was used to detect proteoglycans in mammary tissue sections
only. Sections were first deparafinized and rehydrated. Once this was done, Alcian blue stain,
pH 2.5, was used. Tissues were counterstained with hematoxylin. The tissue sections were then
dehydrated and mounted.

In the second series of experiments, we utilized cell culture models to further explore the
relationship between vitamin D and Has2. Cell lines included the WT145 and KO240
transformed mammary cells which were used for the original microarray screening and the HC11
cells as discussed in section II. The WT145 and KO240 cell lines were originally isolated from
DMBA induced mammary tumors in wild type (WT) or VDRKO mice. For the KOhVDR cells,
the human VDR (HVDR) sequence was stably reintroduced into KO240 cells. The cell lines
were treated with vitamin D as described below and were used to perform western blots and
qPCR studies.

For western blots to detect the Has2 and VDR proteins, cells were treated with ethanol, 100nM
vitamin D, 100nM all trans-retinoic acid (ATRA), or 100nM combo (1:1 mixture of vitamin D
and ATRA). SDS-PAGE separating (7%) and stacking gels and running buffer were mixed and
poured according to the standard protocols.

The gels were loaded with the appropriate samples

with the ladder in lane one and 1X Laemmli Buffer in lane 10. The gels were run at 80V until
samples were well stacked. After this point, the voltage was increase to 130V and gels were
19

allowed to run until the dye line reached the end of the gel. To transfer the gels, two large sheets
and four gel sized sheets of filter paper, and a gel sized sheet of PVDF membrane were cut and
soaked in semi-dry blotting buffer. These were layered on the transfer unit in this order: two
large filter papers, two small filter papers, western gel, transfer membrane, two small filter
papers, and finally two large filter papers. Transfer was allowed to occur for about an hour at
500mAmps. After transfer was complete, the membrane was blocked for 1 hour in 5% skim
milk at room temperature. Next, 500uL of the primary antibody (1/25 dilution for HAS2 and
1/200 dilution for VDR) was pipeted onto the blot, covered in parafilm, and incubated in a
humidity chamber at 4°C overnight.

The next day, the blots were washed three times in PBS. Next, 10mL of secondary antibody
(1:2000 dilution of anti-goat-HRP or anti-mouse-HRP) was put on each blot. After, the blots
were once again washed in PBS 3 times and ECl Plus (1:40) was mixed and applied to each blot
under parafilm. The blots were then covered in aluminum foil and allowed to incubate for 10
minutes. After incubation, each blot was scanned on the Storm scanner.

For qPCR assays, cDNA (complimentary DNA) was prepared and analyzed as described in
Section II for Has1, Has2, Has3, Hyal1, Hyal2, and Hyal3. GAPDH and 18S were used as the
endogenous controls. The cDNA samples were plated in duplicate in a 384 well plate. Once
plating was done, qPCR was performed using the 7900HT Fast Real-Time PCR system (Applied
BioSystems). For each primer, gene expression was normalized to GAPDH and 18S expression.
The data is presented as fold change in gene expression in treated samples relative to vehicle
treated control samples.
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c. Results

In the first series of studies we performed histological analysis of Has2 and HA in tissues from
WT and VDR mice. Staining for Has2 in mammary glands of adult female WT and VDRKO
mice is shown in Figure 3. In tissue from WT mice, Has2 staining is not detected. In contrast
Has2 positive cells were readily detected in tissue from VDRKO mice. The staining for Has2 in
VDRKO mice is localized to a subset of cells in the stroma (likely fibroblasts) which surround
the ducts. Has2 staining in skin from adult WT and VDRKO mice is shown in Figure 4. In WT
mice, the epidermis is thin and orderly, and the dermis contains hair follicles and sweat glands.
Has2 staining was detected in small patches in the dermis, but was not detected at the interface
between the dermis and the epidermis where the basal keratinocytes reside. In contrast, the skin
of VDRKO was markedly abnormal, with thickened epidermis, disordered dermis and aborted
hair follicles. Has2 in skin of the VDRKO mice was highly expressed in the basal keratinocyte
cell layer where the dermis and epidermis meet. Staining in the VDRKO tissue was also detected
in patches within the dermis at levels higher than that seen in WT mice.

WT

VDRKO

Figure 3: Has2 staining in WT and VDRKO mammary glands. The presence of Has2 was
detected with Has2-specific antibody and DAB staining (brown). Sections were
counterstained with hematoxylin to visualize stroma and ducts. Shown are representative
VDRKO
sections of mammaryWT
gland from virgin adult female WT and VDRKO mice.
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Figure 4: Has2 staining in WT and VDRKO skin tissue. The presence of Has2 was
detected with Has2-specific antibody and DAB staining (brown). Sections were
counterstained with hematoxylin to visualize epidermis and dermis.
Shown are
representative sections of skin from adult WT and VDRKO mice.
To determine whether the amount of Has2 detected in WT and VDRKO skin correlated with the
amount of HA, we used a biotinylated HA binding protein (HABP) to localize HA in tissue. As
shown in Figure 3, low levels of HA were present surrounding the mammary ducts of WT mice,
but much larger patches were observed in tissue from VDRKO mice. A similar trend was seen
in mammary tumors removed from WT and VDRKO mice with low abundance of HA in WT
tumors and higher staining in VDRKO tumors. Figure 4 shows HA staining in WT and
VDRKO skin tissue. Similar to the Has2 staining, HA was barely detectable in tissue from WT
mice and was confined to the dermis adjacent to hair follicles and sweat glands. In contrast, the
area surrounding the basal keratinocytes at the interface between the dermis and the epidermis
was heavily stained in tissue from VDRKO mice.

In a final set of experiments we stained

mammary tissue and tumors from WT and VDRKO mice with alcian blue, a general stain for
mucins which detects HA. As shown in Figure 5, Alcian blue staining was similar to HA
staining. Bright blue alcian staining was rarely detected in normal tissue from WT mice but
punctate areas were frequently seen in tissue from VDRKO mice. In tumors, alcian blue staining
was elevated compared to normal tissue, and the differences between WT and VDRKO tissue
was less obvious.
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Ducts

Tumor

WT

VDRKO

Figure 5: HA binding protein (HABP) staining for HA in WT and VDRKO mammary
glands. The presence of HA was detected with biotinylated HABP and DAB (brown)
staining. Shown are representative sections of ducts from normal glands and DMBA-induced
tumors from WT and VDRKO mice.

WT

VDRKO

Figure 6: HA binding protein (HABP) for HA in WT and VDRKO skin samples. The
presence of HA was detected with biotinylated HABP and More DAB (brown) staining
staining. Shown are representative sections from normal skin removed from adult WT and
VDRKO mice.
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Hyperplasia

Tumor

WT

VDRKO

Figure 7: Alcian blue stain for proteoglycans in mammary gland hyperplasias and tumors
from WT and VDRKO mice. Alcian blue staining allows for visualization of HA build-up.
The increased amount of blue staining seen in the VDRKO mammary gland hyperplasias and
tumors indicates HA build-up in these tissues.

In the second series of experiments on Has2, we conducted in vitro trials to measure Has2
regulation in cellular models.We cultured the mouse mammary cells with agents known to alter
Has2 expression including vitamin D and all trans retinoic acid (ATRA, a form of vitamin A)
and prepared cell lysates for western blotting. These experiments were designed to test whether
a commercially available Has2 antibody would successfully detect murine Has2. The results are
shown in Figure 8. Samples include four cell lines (KO240, WT145, KOhVDR4 and HC11 cells)
treated with ethanol, vitamin D, ATRA, or the combination of vitamin D and ATRA. The Has2
protein is 63kDa and should run approximately in the center of a 7% SDS-PAGE gel.
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Unfortunately, it is difficult to determine whether any of the detected bands correspond to Has2,
as there were multiple protein bands present in the central area. An arrow is used to designate
the band that most likely corresponds to the Has2 protein of 63kD.

However, this band is

barely detectable in these murine cell lines, and the data are inconclusive both with respect to
detection of Has2 and with respect to the effects of the various treatments. Further work is
needed to optimize this antibody or test additional antibodies. In Figure 9, the same samples
were blotted with an antibody that detects the VDR protein. In this blot the 50kDa VDR protein
(arrow) is clearly visible in lysates of WT145 and HC11 cells but not in KOhVDR cells or KO240
cells.

The effect of treatment with ethanol, vitamin D, ATRA, or the combination of vitamin D

and ATRA appear to be most pronounced in the WT145 cells, where both vitamin D and the
combination treatments up-regulated VDR expression.

KO240

1

2

3

KOhVDR

WT145

4

5

6

7

8

9

10

1

2

3

HC11

4

5

6

7

8

9

10

Figure 8: Western blot for Has2 in KO240, WT145, KOhVDR, and HC11 cells treated with
100nM EtOH, vitamin D, ATRA, or combo. Cell lysates were separated on SDS-PAGE and
blotted with antibody that recognizes Has2. Arrow indicates expected location of Has2 protein
(63kDa).
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Figure 9: Western blot for VDR in KO240, WT145, KOhVDR, and HC11 cells treated with
100nM EtOH, vitamin D, ATRA, or combo. Cell lysates were separated on SDS-PAGE and
blotted with antibody that recognizes human and mouse VDR. An immunoreactive band at
50kDa represents VDR and is indicated by the arrows.

We also conducted qPCR studies in the KOhVDR and HC11 cell lines to assess expression of Has
and Hyal genes after these treatments. The data are summarized in Figure 10. Based on the
microarray screening and other data from the Welsh lab, it was expected that Has2 would
decrease with vitamin D treatment—however,

we found no change in the expression of Has2

(or any of the other genes examined) in the KOhVDR4 cells. This may reflect the low level of
VDR present in these cells (as evident in Figure 9). Interestingly, ATRA up-regulated all three
Has genes (2-4 fold) and Hyal3 (2-fold). No further increases were observed in cells treated with
both ATRA and vitamin D. In the HC11 cells, the only significant change with vitamin D
treatment was a down regulation of Has2 (-2.8). Although as expected, Has2 was increased in
KOhVDR cells treated with ATRA, no effect of ATRA was observed in HC11 cells.

The

combination treatment in HC11 cells further increased Has2 above that detected with vitamin D
alone, and enhanced the expression of Hyal1, which was up regulated to 8.8. No other changes
of significance were noted.
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KOhVDR4
Has1
Has2
Has3
Hyal1
Hyal2
Hyal3
hVDR

VitD
1.9
-1.1
1.5
1.1
1.1
1.7
-1.2

HC11
ATRA
4
2.3
2.5
1.5
1.2
2.3
1.5

Combo
4
-1.1
2.8
1.3
1.4
4
1.1

VitD
1.5
-2.8
-1.1
-1.1
-1.3
-1.1
N/A

ATRA
1.6
-1.5
-1.1
-1.9
-1
1.1
N/A

Combo
1.2
-3.5
1
8.8
-1
1.4
N/A

Figure 10: Expression of Has and Hyal genes in KOhVDR and HC11 cells. Cells were
treated with ethanol vehicle, 100nM 1,25D, 100nM ATRA or both 1,25D and ATRA for 24
hours. RNA was isolated and used for qPCR with gene-specific primers and GAPHDH for
normalization. Data are expressed as fold change of vehicle treated cells.

d. Discussion

Based on previous data from the Welsh laboratory showing that vitamin D suppresses Has2
gene expression in vitro, we further examined the regulation of hyaluronan metabolism in cell
and mouse models. We hypothesized that if vitamin D is a physiologic regulator of Has2, then
both Has2 and HA would be increased in tissues from VDRKO mice. Through histological
approaches we visualized Has2 and HA in normal tissue and tumors derived from skin and
mammary gland of WT and VDRKO mice. Our data strongly suggests that Has2 is elevated in
VDRKO tissue, most dramatically in the skin. The up-regulation of Has2 in both skin and
mammary gland was correlated with increased abundance of HA as detected with HABP and
Alcian blue staining. Collectively, these data indicate that tissues lacking functional VDR
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exhibit increased Has2 and HA which col-localize. Thus, these data support our hypothesis that
VDR deficiency would result in up-regulation of Has2 .

One implication of our findings is that suppression of Has2 and HA by vitamin D contributes to
the control of cell proliferation and differentiation in the mammary gland and skin. These two
tissues are highly susceptible to carcinogenesis in the absence of the VDR (Zinser et al, 2002;
2005). Because HA exerts tumor promoting actions, it is possible that the suppression of Has2
and HA by vitamin D may explain why VDRKO mice have increased susceptibility to skin
cancer.

In addition, it is possible that the excess Has2 contributes to the abnormal skin

phenotype in the VDRKO mice, since Has2 has recently been linked to the wrinkly skin
phenotype of Shar-Pei dogs (Olsson et al, 2011). The final implication of our findings is the
potential relevance of vitamin D to human skin cancer. The VDRKO mice are an accurate
model for a human genetic condition characterized by VDR mutations which render the VDR
non-functional. In this condition, the development of the hair follicle in the skin is disturbed,
resulting in the same bald phenotype as observed in the VDRKO mice. Thus, the abnormalities
in the VDRKO skin, including the accumulation of HA, may shed light onto the role of VDR in
human skin and hair function. Since the VDR exerts similar functions in mouse and human
mammary glands and skin, optimal vitamin D status may exert protection against human breast
and skin cancer, as has been suggested by epidemiological studies.

With respect to the final cell studies on Has2 expression and vitamin D, further work is needed to
validate our findings. The western blot for Has2 showed multiple bands and is therefore
inconclusive as it is difficult to locate the specific protein band that corresponds to Has2. To fix
this problem, additional blots should be conducted to optimize the antibody staining for detection
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of Has2. Once optimized it will be necessary to normalize and quantitate Has2 expression
between different treatments. The VDR blot must also be repeated because no VDR was
detected in the KOhVDR4 cells. This might reflect insufficient protein loading in these lanes or a
change in the cell line itself that caused loss of the ectopic VDR. Furthermore, it is necessary to
repeat all these experiments since not enough replicates were performed to ascertain the
reproducibility of the results. It will be especially important to repeat the PCR and western blot
experiments to conclusively demonstrate the link between vitamin D, the VDR and Has2 in
relation to tumorigenesis.
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IV. OVERALL CONCLUSIONS

In this thesis I conducted laboratory research focused on the molecular actions of vitamin D
especially in relation to protection against chronic diseases such as cancer. Although the initial
cytokine studies were conducted in normal cells, they support a role for vitamin D in regulation
of inflammation, which is intimately involved with cancer progression. Our data provides
evidence that the anti-inflammatory effects of IL10 are increased in the presence of vitamin D.
Importantly, we also observed differences in the effects of vitamin D on cytokines in normal
mammary cells versus breast cancer cells. The loss of vitamin D control over immune gene
regulation may be an important contributor to cancer initiation or progression in the mammary
gland. We also provide evidence that VDR, the receptor for active forms of vitamin D, exerts
anti-cancer effects in skin and mammary tissue through the suppression of Has2.

The

suppression of Has2 by vitamin D and the VDR would be expected to inhibit the cancer process
because high levels of Has2 and its product HA are known to promote cell proliferation and
cancer.

Although these experiments were performed using cell and mouse models,

epidemiological studies have consistently linked low vitamin D status with increased risk for
cancer in many tissues.

Thus, further studies are warranted to mechanistically investigate

whether regulation of cytokines or HA production by vitamin D in the context of human cancer.
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